A nurse is caring for a client who received a liver transplant 1 year ago and is on immunosuppressive therapy. The client reports feeling fatigued and has developed multiple skin lesions. Laboratory results show a decreased white blood cell count. What is the priority nursing intervention?

Immunocompromised transplant recipients with fatigue, skin lesions, and decreased WBC are at high infection risk. The priority is strict infection control precautions to prevent complications.

Understanding the Clinical Scenario

The client is a liver transplant recipient on long-term immunosuppressive therapy presenting with a triad of concerning symptoms: fatigue, multiple skin lesions, and a decreased white blood cell (WBC) count. In the context of immunosuppression, this clinical picture strongly suggests an evolving infectious process or a complication related to immunomodulation. The priority is to recognize that immunosuppressive therapy impairs the body's ability to mount an effective immune response, making the client highly vulnerable to opportunistic infections and atypical presentations of common pathogens.

Pathophysiology and Clinical Reasoning

Immunosuppressive agents, such as calcineurin inhibitors (e.g., tacrolimus) and antimetabolites (e.g., azathioprine, mycophenolate mofetil), work by inhibiting T-cell and B-cell proliferation and function. While essential for preventing graft rejection, this T-cell suppression creates a state of profound immune dysfunction. The provided literature highlights how this state predisposes patients to a range of severe infections, from viral reactivations like cytomegalovirus (CMV) and Epstein-Barr virus (EBV) to opportunistic parasitic infections like Cryptosporidium [1,3]. The development of skin lesions and a low WBC count (leukopenia) is a critical alarm. Leukopenia, a common adverse effect of medications like mycophenolate mofetil, further compounds the infection risk. The skin lesions could represent a primary infection, a disseminated systemic infection, or even a posttransplant lymphoproliferative disorder (PTLD), which is strongly linked to EBV and immunosuppression ^[1]. Any break in the skin’s integrity in a leukopenic, immunosuppressed patient is a potential portal of entry for pathogens and a source for systemic dissemination.

Analysis of Options

- Option 1 (Incorrect): Encouraging increased physical activity to combat fatigue is contraindicated. Fatigue in this context is a systemic symptom likely indicative of an underlying infection or a medication side effect, not simple deconditioning. Increasing activity could place metabolic stress on a patient who may be in the early stages of sepsis. The priority is to identify and treat the underlying cause, not to manage the symptom in isolation.

- Option 2 (Correct): Implementing strict infection control precautions and monitoring for signs of infection is the priority. The combination of immunosuppression, new skin lesions, and leukopenia creates a perfect storm for a life-threatening infection. As noted in the literature, infections in these patients can present with subtle signs and progress rapidly to severe states like acute liver failure or severe sepsis [2,4]. Immediate protective isolation and vigilant monitoring for subtle changes in vital signs, mental status, and respiratory function are essential for early detection and intervention.

- Option 3 (Incorrect): Applying topical antibiotics to skin lesions is a secondary intervention. While local wound care is important, it does not address the systemic vulnerability. The skin lesions may be a cutaneous manifestation of a systemic infection like CMV or a fungal pathogen, which would not respond to topical antibiotics. The immediate priority is to protect the patient from further nosocomial exposure and to conduct a full diagnostic workup to determine the etiology of the lesions and leukopenia.

- Option 4 (Incorrect): Discontinuing immunosuppressive medications immediately is a dangerous action that must only be performed under the direct order of the transplant team. Abrupt cessation can precipitate acute graft rejection, leading to rapid liver failure. The management of a suspected infection in a transplant recipient involves a delicate balance of reducing immunosuppression (guided by the provider), initiating targeted antimicrobial therapy, and closely monitoring graft function. The nurse's role is to recognize the emergency, implement protective measures, and notify the provider immediately, not to independently alter the medication regimen.

The Priority Nursing Intervention

The nurse must recognize that the client’s chief defense—the immune system—is pharmacologically impaired. The presence of skin lesions and a low WBC count are objective data points that signal a high risk for systemic infection and sepsis. The immediate nursing action is to institute protective isolation (strict hand hygiene, private room, appropriate personal protective equipment) and perform a focused assessment for early, often subtle, signs of infection such as low-grade fever, tachycardia, or confusion. This approach aligns directly with the evidence that delayed diagnosis and treatment of infections in immunocompromised hosts lead to catastrophic outcomes, including severe organ failure and death [2,4].